Concentrations of the Stress Hormone Copeptin Increase upon Hypoglycaemia in Patients with Type 1 Diabetes Dependent of Hypoglycaemia Awareness

被引:12
|
作者
Seelig, Eleonora [1 ]
Bilz, Stefan [2 ]
Keller, Ulrich [1 ]
Meienberg, Fabian [1 ]
Christ-Crain, Mirjam [1 ]
机构
[1] Univ Basel Hosp, Dept Diabetol Endocrinol & Metab, CH-4031 Basel, Switzerland
[2] Kantonsspital, Dept Endocrinol, St Gallen, Switzerland
来源
PLOS ONE | 2013年 / 8卷 / 08期
关键词
INSULIN-INDUCED HYPOGLYCEMIA; ARGININE-VASOPRESSIN; STABLE PEPTIDE; PRECURSOR; PLASMA; SECRETION; RESPONSES; FAILURE; ASSAY;
D O I
10.1371/journal.pone.0072876
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objective: Copeptin, a marker for stress mirroring vasopressin concentrations, has been shown to increase upon insulin-induced hypoglycaemia in patients after transsphenoidal surgery of pituitary adenomas. Patients with type 1 diabetes mellitus are prone to hypoglycaemia, but no data about copeptin levels upon hypoglycaemia are available. Furthermore, the perception of hypoglycaemia can vary from total unawareness to disabling episodes. The aim of this study was to investigate whether copeptin increases upon hypoglycaemia in patients with type 1 diabetes mellitus and is associated with the degree of hypoglycaemia awareness. Materials and Methods: In this prospective observational study, 17 patients with type 1 diabetes underwent a standardized insulin infusion test. Blood sampling for glucose and copeptin was performed at baseline and after 60 minutes (min). To assess hypoglycaemia associated symptoms the Mood and Symptom Questionnaire (MSQ) was conducted at baseline and after 60 min. Results: During insulin infusion, blood glucose decreased from 5.1 (SD +/- 0.2) to 3.0 (+/- 0.5) mmol/L at 60 min (p<0.001). Copeptin concentrations increased from 3.2 (+/- 1.7) to 3.8 (+/- 1.9) pmol/L (p = 0.03). Mood and Symptoms Questionnaire scores increased from 14 (+/- 3.0) to 18 (+/- 5.8), (p = 0.006). Patients with good hypoglycaemia awareness had an increase in copeptin from 3.0 (+/- 1.8) to 4.2 (+/- 2.4) pmol/L (p = 0.03) in contrast to patients more unaware of hypoglycaemia who only showed an increase in copeptin from 3.3 (+/- 1.6) to 3.6 (+/- 1.4) pmol/L (p = 0.4). There was a trend to a larger copeptin increase in patients aware of hypoglycemia compared to patients unaware of hypoglycemia (p = 0.074). Conclusion: Copeptin increases in patients with type 1 diabetes upon insulin induced hypoglycaemia. Interestingly, the copeptin increase seems associated with the degree of hypoglycaemia awareness. This hypothesis warrants further verification.
引用
收藏
页数:4
相关论文
共 50 条
  • [31] Glucagon dynamics during hypoglycaemia and food-re-challenge following treatment with vildagliptin in insulin-treated patients with type 2 diabetes
    Farngren, J.
    Persson, M.
    Schweizer, A.
    Foley, J. E.
    Ahren, B.
    DIABETES OBESITY & METABOLISM, 2014, 16 (09) : 812 - 818
  • [32] Hypoglycaemia leads to a delayed increase in platelet and coagulation activation markers in people with type 2 diabetes treated with metformin only: Results from a stepwise hypoglycaemic clamp study
    Aberer, Felix
    Pferschy, Peter N.
    Tripolt, Norbert J.
    Sourij, Caren
    Obermayer, Anna M.
    Prueller, Florian
    Novak, Eva
    Reitbauer, Philipp
    Kojzar, Harald
    Prietl, Barbara
    Kofler, Selina
    Brunner, Martina
    Svehlikova, Eva
    Stojakovic, Tatjana
    Scharnagl, Hubert
    Oulhaj, Abderrahim
    Aziz, Faisal
    Riedl, Regina
    Sourij, Harald
    DIABETES OBESITY & METABOLISM, 2020, 22 (02) : 212 - 221
  • [33] Metabolic Implications when Employing Heavy Pre- and Post-Exercise Rapid-Acting Insulin Reductions to Prevent Hypoglycaemia in Type 1 Diabetes Patients: A Randomised Clinical Trial
    Campbell, Matthew D.
    Walker, Mark
    Trenell, Michael I.
    Luzio, Steven
    Dunseath, Gareth
    Tuner, Daniel
    Bracken, Richard M.
    Bain, Stephen C.
    Russell, Mark
    Stevenson, Emma J.
    West, Daniel J.
    PLOS ONE, 2014, 9 (05):
  • [34] Differential effects of insulin detemir and neutral protamine Hagedorn (NPH) insulin on hepatic glucose production and peripheral glucose uptake during hypoglycaemia in type 1 diabetes
    Smeeton, F.
    Moradie, F. Shojaee
    Jones, R. H.
    Westergaard, L.
    Haahr, H.
    Umpleby, A. M.
    Russell-Jones, D. L.
    DIABETOLOGIA, 2009, 52 (11) : 2317 - 2323
  • [35] Liraglutide as adjunct to insulin treatment in type 1 diabetes does not interfere with glycaemic recovery or gastric emptying rate during hypoglycaemia: A randomized, placebocontrolled, double-blind, parallel-group study
    Frandsen, Christian S.
    Dejgaard, ThomasF.
    Andersen, Henrik U.
    Holst, Jens J.
    Hartmann, Bolette
    Thorsteinsson, Birger
    Madsbad, Sten
    DIABETES OBESITY & METABOLISM, 2017, 19 (06) : 773 - 782
  • [36] Effect of targeting normal fasting glucose levels with basal insulin glargine on glycaemic variability and risk of hypoglycaemia: a randomized, controlled study in patients with early Type 2 diabetes
    Hanefeld, M.
    Koehler, C.
    Hoffmann, C.
    Wilhelm, K.
    Kamke, W.
    Gerstein, H.
    DIABETIC MEDICINE, 2010, 27 (02) : 175 - 180
  • [37] Hypoglycemia-Associated Changes in the Electroencephalogram in Patients With Type 1 Diabetes and Normal Hypoglycemia Awareness or Unawareness
    Sejling, Anne-Sophie
    Kjaer, Troels W.
    Pedersen-Bjergaard, Ulrik
    Diemar, Sarah S.
    Frandsen, Christian S. S.
    Hilsted, Linda
    Faber, Jens
    Holst, Jens J.
    Tarnow, Lise
    Nielsen, Martin N.
    Remvig, Line S.
    Thorsteinsson, Birger
    Juhl, Claus B.
    DIABETES, 2015, 64 (05) : 1760 - 1769
  • [38] Improved glycaemic control with minimal hypoglycaemia and no weight change with the once-daily human glucagon-like peptide-1 analogue liraglutide as add-on to sulphonylurea in Japanese patients with type 2 diabetes
    Kaku, K.
    Rasmussen, M. F.
    Clauson, P.
    Seino, Y.
    DIABETES OBESITY & METABOLISM, 2010, 12 (04) : 341 - 347
  • [39] Effect of hypoglycaemia on measures of myocardial blood flow and myocardial injury in adults with and without type 1 diabetes: A prospective, randomised, open-label, blinded endpoint, cross-over study
    Noh, Radzi M.
    Graveling, Alex J.
    Lang, Ninian N.
    White, Audrey C.
    Lee, Kuan K.
    Mills, Nicholas L.
    Newby, David E.
    Lang, Chim C.
    Frier, Brian M.
    ENDOCRINOLOGY DIABETES & METABOLISM, 2021, 4 (03)
  • [40] Impact of postprandial and fasting glucose concentrations on HbA1c in patients with type 2 diabetes
    Schernthaner, G.
    Guerci, B.
    Gallwitz, B.
    Rose, L.
    Nicolay, C.
    Kraus, P.
    Kazda, C.
    DIABETES & METABOLISM, 2010, 36 (05) : 389 - 394